Is GBL legal in United Arab Emirates?

Legal status

Gamma-butyrolactone is expressly listed at Schedule 8, item 39 of Decision No. 158 of 2025, at the printed entry «جي بي إل؛ غاما-بوتيرولاكتون», with the dossier rendering the chemical name as dihydrofuran-2(3H)-one. The express listing is the finding: this compound is an industrial solvent as well as a precursor that converts in the body to the substance carried in Schedule 6, and in a country that controlled only the end product it would be argued about. Here it is named, so its status does not depend on the conversion argument. Note the split that follows: the lactone is Schedule 8 and the hydroxybutyrate is Schedule 6, two different schedules within the same Article 58 group. The row runs through Articles 11, 43 and 58, with Schedule 10 group 3 carrying the quantity band. The placement was read on 20 September 2026.

Consequences if caught

Article 58 reaches Schedules 3, 6, 7 and 8, and this compound is at Schedule 8, item 39, so the article applies. The dossier records Article 58 as providing death or life imprisonment as alternatives for its stated trafficking or promotion trigger, so death is discretionary rather than mandatory, and it records that the article states no quantity. The Schedule 10 group 3 band does not gate that route. Because the substance has genuine industrial uses, the conduct rather than the possession is where the article bites, and there is no volume at which the trafficking or promotion trigger becomes unavailable. Article 43 carries the personal use route for this branch, with its tariff unstated in the dossier.

If prescribed or medical

The dossier records at the modafinil row that a 268 entry ministry travellers list was checked and expressly not used as a schedule. Attached to this substance: the placement at Schedule 8, item 39, with no medicinal product behind it, since this compound is a solvent and a precursor rather than a medicine. No prescribing route or permit procedure is recorded, and the dossier does not describe any industrial licensing route either, so both questions are deferred rather than answered.

Documentation

No medical documentation route is recorded for this substance, and the dossier describes no industrial or commercial licence for it either. Provenance: the entry «جي بي إل؛ غاما-بوتيرولاكتون» at Schedule 8, item 39 was read on 20 September 2026, with the capital analysis resting on Article 58 and its death or life alternative rather than on the Schedule 10 group 3 band. The point worth carrying is that a container labelled as a cleaning or industrial product contains a named scheduled substance, and the label does not change the entry.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with United Arab Emirates’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.